PHTPP

This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 06:23, 29 December 2015 (Created page with '{{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol | ima...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

PHTPP is a synthetic, non-steroidal, and highly selective antagonist of ERβ that is used in scientific research to study the function of this receptor.[1][2] It possesses 36-fold selectivity for ERβ over ERα, and is a silent antagonist of ERβ.[3]

PHTPP
Identifiers
  • 4-[2-Phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H11F6N3O
Molar mass423.311259 g/mol g·mol−1
3D model (JSmol)
  • C1=CC=C(C=C1)C2=NN3C(=CC(=NC3=C2C4=CC=C(C=C4)O)C(F)(F)F)C(F)(F)F

See also

References

  1. ^ Neurosteroids. Frontiers E-books. pp. 95–. ISBN 978-2-88919-078-2.
  2. ^ Cytoplasmic and Nuclear Receptors—Advances in Research and Application: 2012 Edition. ScholarlyEditions. 26 December 2012. pp. 220–. ISBN 978-1-4649-9741-9.
  3. ^ Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA (2004). "Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity". J. Med. Chem. 47 (24): 5872–93. doi:10.1021/jm049631k. PMID 15537344.